OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Kevin Hodgetts

2 Projects | 1 Researchers | $753,410 Invested

2018

Laboratory for Drug Discovery in neurodegeneration (LDDN)

Kevin Hodgetts, PhD

Novel Benzoxazines for the Treatment of Alzheimer's Disease

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed

2016

The Laboratory for Drug Discovery in Neurodegeneration

Kevin Hodgetts, PhD

Chiral Switching and Drug Repurposing: Evaluation of (R)-Ricobendazole in the Tau mouse model (rTG4510) of AD

  • Funding Amount: $153,410
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Closed